ABSTRACT
Measures promoting active mobility - walking or cycling - are often seen as an effective strategy to meet multiple urban objectives. The advantages of such behavioural changes cover multiple dimensions at public and individual level, including positive impacts on health, safety, climate, economy, environment and air quality. However, there is still a considerable potential for increasing the uptake of active mobility in urban areas. This paper explores the determinants of active mobility choice and compares the demographic, socio-economic and cultural factors that influence it. The methodology combines extensive survey data, an EU-wide transport model and detailed indicators of external costs of transport with a Gradient Boosting Machine Learning approach. The model based scenarios quantify the benefit in terms of external costs savings from increasing active mobility shares. Such savings - at EU level, can reach the amount of 15 billion euro per year for a shift of 10% of trips to active mobility modes.
Subject(s)
Air Pollution , Bicycling , Climate , Income , Transportation , WalkingABSTRACT
BACKGROUND: A previous European study found a longer time to pregnancy (TTP) among fertile women from Paris compared with women from other Western European countries. A co-ordinated, cross-sectional study of pregnant couples from Denmark (Copenhagen), France (Paris), Scotland (Edinburgh) and Finland (Turku) was therefore undertaken to assess differences in waiting TTP among couples from these cities. METHODS: Pregnant women were invited to participate when they showed up for their first antenatal visit in one of the four centres. Inclusion criteria included that their partner was 20-45 years of age and born in the country in which he was currently living and that the pregnancy was achieved without fertility treatment. Both partners filled in a questionnaire and the man underwent a physical examination and delivered a semen sample (Turku: n = 237, Copenhagen: n = 302, Edinburgh: n = 212, Paris: n = 191). RESULTS: French couples had a decreased probability of conception compared with couples from the other three countries, although only after adjustment for confounders. No significant differences between couples from the three other countries were found. CONCLUSION: The observed geographical differences in TTP remain unexplained and were not due to differences in semen quality, but may be caused by varying exposures to environmental factors or psychological distress. In addition, selection bias due to the low participation rates cannot be ruled out. Future studies examining the causes for geographical differences in TTP are needed.
Subject(s)
Fertility , Infertility/epidemiology , Adult , Age Factors , Cross-Sectional Studies , Denmark/epidemiology , Educational Status , Environment , Female , Finland/epidemiology , France/epidemiology , Humans , Infertility/etiology , Male , Middle Aged , Parity , Pregnancy , Scotland/epidemiology , Semen/physiology , Sperm Count , Stress, Psychological , Surveys and Questionnaires , Time FactorsABSTRACT
Animal studies and human intervention trials have demonstrated the cancer chemopreventive properties of plant phytoestrogens, and phytoestrogen supplements are now widely available 'over-the-counter'. However, consumption of phytoestrogen-rich diets can cause impaired fertility and reproductive tract disorders in some animals and the apparent decline in human sperm quality over recent decades may be related to increased exposure to environmental endocrine disruptors. The present study determines the effects of a short-term phytoestrogen supplement on semen quality and serum sex steroid and gonadotrophin levels in human males. Healthy volunteers took a supplement containing 40 mg of isoflavones daily for 2 months and donated blood and semen samples monthly for 2 months before and 4 months after supplementation. Semen samples were analysed for ejaculate volume, sperm concentration, total sperm count, motility and morphology. Blood samples were analysed for sex hormone and gonadotrophin levels and phytoestrogen concentrations, and testicular volume was measured using an orchidometer. The phytoestrogen supplement increased plasma genistein and daidzein concentrations to approx. 1 microM and 0.5 microM respectively; yet, there was no observable effect on endocrine measurements, testicular volume or semen parameters over the study period. This is the first study to examine the effects of a phytoestrogen supplement on reproductive health in males. We conclude that the phytoestrogen dose consumed had no effect on semen quality.
Subject(s)
Dietary Supplements , Estrogens, Non-Steroidal/pharmacology , Fertility/drug effects , Semen/drug effects , Adult , Genistein/blood , Gonadal Steroid Hormones/blood , Gonadotropins, Pituitary/blood , Humans , Isoflavones/blood , Male , Phytoestrogens , Plant Preparations , Glycine max , Sperm Count , Sperm Motility/drug effects , Spermatozoa/cytology , Testis/anatomy & histology , Testis/drug effectsABSTRACT
Recent reports have indicated a decrease in semen quality of men in some countries, and suggested regional differences. A study was undertaken of semen samples from 1082 fertile men from four European cities (Copenhagen, Denmark; Paris, France; Edinburgh, Scotland; and Turku, Finland). Semen analysis was standardized, inter-laboratory differences in assessment of sperm concentration were evaluated, and morphology assessment centralized. Lowest sperm concentrations and total counts were detected for Danish men, followed by French and Scottish men. Finnish men had the highest sperm counts. Men from Edinburgh had the highest proportion of motile spermatozoa, followed by men from Turku, Copenhagen and Paris. Only the differences between Paris/Edinburgh and Paris/Turku were statistically significant (P < 0.003 and P < 0.002 respectively). No significant differences in morphology were detected. A general seasonal variation in sperm concentration (summer 70% of winter) and total sperm count (summer 72% of winter) was detected. Semen quality of a 'standardized' man (30 years old, fertile, ejaculation abstinence of 96 h) were estimated. Typically, sperm concentrations (x 10(6)/ml) for winter/summer were: Turku 132/93; Edinburgh 119/84; Paris 103/73; and Copenhagen 98/69. These differences in semen quality may indicate different environmental exposures or lifestyle changes in the four populations. However, it remains to be seen whether such changes can account for these differences. These data may also serve as a reference point for future studies on time trends in semen quality in Europe.
Subject(s)
Semen/physiology , Sperm Count , Sperm Motility , Adult , Aging , Chlamydia Infections/complications , Chlamydia Infections/epidemiology , Denmark , Ejaculation , Europe , Female , Finland , France , Humans , Infertility, Male/epidemiology , Infertility, Male/etiology , Infertility, Male/pathology , Male , Pregnancy , Scotland , Seasons , Testis/pathology , Time FactorsABSTRACT
Hormone replacement therapy (HRT) is effective in alleviating vasomotor symptoms but the effect on psychological symptoms is less clear. This study aimed to compare the psychological effects of two regimens of HRT in perimenopausal women in a randomized, initially double-blind, controlled trial. Thirty-eight women reporting climacteric symptoms were randomly allocated into either oral conjugated equine estrogen 0.625 mg daily plus progestogen (norgestrel) 150 micrograms for the last 12 days of each 28 day cycle, or tibolone 2.5 mg/day for 28 days. They were assessed using standardized psychological assessments. There were no significant differences in changes from baseline between the two types of therapy. For both groups combined there were significant improvements compared with baseline in vasomotor symptoms in the first month, plus anxiety, sleep, memory and somatic dysfunction by the second and third months, but not in scores of depression. Log linear analysis of weekly scores showed that depression scores were significantly related to improvement in vasomotor scores independent of type of therapy and time on HRT. Memory problems were related to vasomotor symptoms independent of depression. No difference between the two types of therapy was found, nor any direct effect of HRT on anxiety or depression. The results support the domino theory, suggesting that psychological improvement follows alleviation of vasomotor symptoms.
Subject(s)
Anabolic Agents/therapeutic use , Estrogen Replacement Therapy/psychology , Estrogens, Conjugated (USP)/therapeutic use , Norgestrel/therapeutic use , Norpregnenes/therapeutic use , Premenopause/drug effects , Premenopause/psychology , Progesterone Congeners/therapeutic use , Aged , Anxiety/prevention & control , Depression/prevention & control , Double-Blind Method , Female , Humans , Linear Models , Middle Aged , Premenopause/physiology , Prospective StudiesABSTRACT
An increase in the activity of the hypothalamic-pituitary-adrenal axis (HPA axis) is frequently associated with major depression. During the premenstrual phase of their reproductive cycle some women experience depressive mood changes that are proposed to be of similar intensity to that experienced during periods of major depression. This study examined the secretion of cortisol, the end-product in the HPA axis, at different stages of the menstrual cycle in women with and without premenstrual depression. Women who experienced only mild physical and emotional changes in the premenstrual phase of their cycle had a significantly higher cortisol secretion on a premenstrual day (measured hourly) compared to a postmenstrual day. Those who were significantly more depressed premenstrually showed the opposite pattern of cortisol secretion with significantly lower levels on the premenstrual day compared with the postmenstrual day. Across the menstrual cycle, women who were significantly more depressed premenstrually also had lower evening cortisol levels in their premenstrual phase. The results of this study indicate that, unlike major depression where the underlying neurological changes are manifest as overactivity of the HPA axis, premenstrual depressive changes are associated with reduced HPA axis activity. Premenstrual depression may, therefore, be similar neurologically to seasonal affective disorder, which is associated with underactivity of the HPA axis.
Subject(s)
Affect/physiology , Circadian Rhythm/physiology , Hydrocortisone/metabolism , Menstrual Cycle/physiology , Premenstrual Syndrome/physiopathology , Saliva/metabolism , Adult , Analysis of Variance , Cross-Over Studies , Depression/metabolism , Female , Humans , Middle Aged , Psychiatric Status Rating ScalesABSTRACT
OBJECTIVE: The impact of the menopause on androgen production is poorly understood. We have investigated the impact of the menopause, as well as other factors such as age, body mass index (BMI) and cigarette smoking, on ovarian and adrenal androgen levels in women aged 40-60 years. DESIGN: Cross-sectional study of blood hormones sampled weekly over one month in volunteer 40-60-year-old women. SUBJECTS: One hundred and forty-one women, aged between 40 and 60, recruited from community sources (non-clinical), not using hormone replacement or steroidal contraceptives, and with a current sexual partner. Fifty were categorized as premenopausal (ovulating), 37 as perimenopausal and 54 as post-menopausal. MEASUREMENTS: The following variables were assessed; menopausal status (based on menstrual history and pattern and plasma progesterone), age, BMI, smoking, oestradiol (E2), oestrone (E1), LH, FSH, total testosterone (TT), androstenedione (A), SHBG, free androgen index (FAI), dihydroepiandrosterone (DHEA), dihydroepiandrosterone sulphate (DHEAS) and cortisol. RESULTS: are based on multiple regression analysis. TT was positively related to A, BMI and LH. A was negatively related to age and FSH, and positively to DHEA, DHEAS and premenopausal status. SHBG was negatively related to BMI and positively to E1 and non-smoking. DHEA and DHEAS were negatively related to age and were higher in smokers. Both E1 and E2 were related to menopausal status and to FSH. Surprisingly, E2 was negatively related to BMI. CONCLUSIONS: A variety of factors influence androgen production in this age group. Whereas it is difficult to predict the effect of menopause on androgen levels, LH stimulation of post-menopausal interstitial cells, modulated by a variety of factors including nutrition, and smoking, are likely to be relevant.
Subject(s)
Adrenal Glands/metabolism , Androgens/blood , Menopause/metabolism , Ovary/metabolism , Adult , Age Factors , Androstenedione/blood , Body Mass Index , Dehydroepiandrosterone/blood , Dehydroepiandrosterone Sulfate/blood , Estradiol/blood , Estrone/blood , Female , Follicle Stimulating Hormone/blood , Humans , Luteinizing Hormone/blood , Middle Aged , Progesterone/blood , Regression Analysis , Smoking/metabolism , Testosterone/bloodABSTRACT
One hundred and forty-one women, aged 40-60 years, recruited from the community were assessed with an initial interview, plus four interviews at intervals of 1 week and blood samples. The objective was to investigate the determinants of sexuality and well-being in this sample. Measures included interview ratings of sexual function, Frenken Sexual Experience Scales and the Multiple Affect Adjective Check List. Determinants evaluated, using multiple regression analysis, included age, menopausal status, BMI, smoking, ovarian steroids and adrenal androgens. None of the hormonal parameters significantly predicted measures of sexuality; the most important predictors were other aspects of the sexual relationship, sexual attitudes and measures of well-being. The best predictor of both well-being and depression was tiredness. The only hormone positively related to well-being was dehydroepiandrosterone (DHEA).
Subject(s)
Gonadal Steroid Hormones/physiology , Menopause/physiology , Menopause/psychology , Sexuality/physiology , Sexuality/psychology , Steroids/physiology , Women's Health , Adult , Affect/physiology , Analysis of Variance , Chi-Square Distribution , Climacteric/physiology , Climacteric/psychology , Dehydroepiandrosterone/blood , Dehydroepiandrosterone/physiology , Depression/physiopathology , Female , Gonadal Steroid Hormones/blood , Humans , Longitudinal Studies , Middle Aged , Multivariate Analysis , Regression Analysis , Sampling Studies , Steroids/bloodABSTRACT
OBJECTIVE: To determine whether the quality of semen has changed in a group of over 500 Scottish men born between 1951 and 1973. DESIGN: Retrospective review of data on semen quality collected in a single laboratory over 11 years and according to World Health Organisation guidelines. SETTING: Programme of gamete biology research funded by Medical Research Council. SUBJECTS: 577 volunteer semen donors. Of these, 171 were born before 1959, 120 were born in 1960-4, 171 in 1965-9, and 115 in 1970-4. MAIN OUTCOME MEASURES: Conventional criteria of semen quality including semen volume (ml), sperm concentration (10(6)/ml), overall motility (% motile), total number of sperm in the ejaculate (10(6)), and total number of motile sperm in the ejaculate (10(6)). RESULTS: When the four birth cohort groups were compared a later year of birth was associated with a lower sperm concentration, a lower total number of sperm in the ejaculate, and a lower number of motile sperm in the ejaculate. The median sperm concentration fell from 98x10(6)/ml among donors born before 1959 to 78x10(6)/ml among donors born after 1970 (P=0.002). The total number of sperm in the ejaculate fell from 301x10(6) to 214x10(6) (P=0.0005), and the total number of motile sperm in the ejaculate fell from 169.7x10(6) to 129.0x10(6) (P=0.0065). CONCLUSION: This study provides direct evidence that semen quality is deteriorating, with a later year of birth being significantly associated with a reduced number of sperm in adult life.
Subject(s)
Oligospermia/epidemiology , Semen/physiology , Adult , Aged , Cohort Studies , Humans , Male , Middle Aged , Regression Analysis , Retrospective Studies , Scotland/epidemiology , Sperm Count , Sperm MotilitySubject(s)
Insemination, Artificial, Heterologous , Semen , Tissue Donors/psychology , Adult , Humans , MaleABSTRACT
Four hundred and six insulin-dependent diabetic women completed a Menstrual Health Questionnaire published in Balance. Sixty-seven percent of women experienced changes in blood glucose levels or glycosuria premenstrually and 70% during the menstrual phase. Changes were more common in women who regarded themselves as suffering from premenstrual syndrome. Those experiencing premenstrual craving for sweet foods tended to have higher blood glucose levels or more glycosuria at those times. This may be a consequence of some women indulging their craving. Premenstrual symptoms were not caused by hypoglycaemia. When compared with age-matched non-diabetic women responding to a similar questionnaire, the diabetic women had a later menarche and, among those not on steroidal contraceptives, were more likely to report very irregular menstrual cycles. Among those regarding themselves as sufferers of premenstrual syndrome, diabetic women had less severe premenstrual symptoms than non-diabetic women. When women from these two self-designated premenstrual [corrected] syndrome suffering groups were matched for severity of premenstrual depression, differences still persisted in the severity of some symptoms perimenstrually, raising the possibility that in some way diabetes may alter women's experience of menstrual cycle-related symptoms.
Subject(s)
Blood Glucose/metabolism , Diabetes Mellitus, Type 1/physiopathology , Dysmenorrhea/epidemiology , Menstruation/physiology , Premenstrual Syndrome/epidemiology , Adolescent , Adult , Contraception , Diabetes Mellitus, Type 1/blood , Dysmenorrhea/blood , Female , Humans , Male , Middle Aged , Premenstrual Syndrome/blood , Reference Values , Surveys and QuestionnairesABSTRACT
The aim was to determine if certain risk factors in the general population are more strongly related to peripheral arterial disease than to ischemic heart disease. Arterial disease in the lower limbs was measured by means of the World Health Organization questionnaire on intermittent claudication, the ankle brachial pressure index, and a reactive hyperemia test in 1,592 men and women aged 55-74 years selected randomly in 1988 from the age-sex registers of 10 general practices in Edinburgh, Scotland. Peripheral arterial disease was strongly related to lifetime cigarette smoking, with additional risks in current and exsmokers of less than 5 years. Multiple regression of risk factors on measures of peripheral arterial disease showed associations with diabetes mellitus (but not impaired glucose tolerance), systolic blood pressure, and serum cholesterol; inverse association with high-density lipoprotein cholesterol; and only univariate association with triglycerides. In multiple logistic regressions of risk factors on six separate indicators of cardiovascular disease, the only consistent difference was that smoking increased the risk of peripheral arterial disease (range of odds ratios, 1.8-5.6) more than heart disease (range of odds ratios, 1.1-1.6). Diabetes mellitus was not a stronger risk factor for peripheral arterial disease.
Subject(s)
Arteriosclerosis/epidemiology , Coronary Disease/epidemiology , Diabetes Complications , Hypercholesterolemia/complications , Hypertension/complications , Peripheral Vascular Diseases/epidemiology , Smoking/adverse effects , Aged , Analysis of Variance , Arteriosclerosis/etiology , Cholesterol, HDL/blood , Coronary Disease/etiology , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Multivariate Analysis , Peripheral Vascular Diseases/etiology , Regression Analysis , Risk Factors , Scotland/epidemiology , Triglycerides/bloodABSTRACT
Intermittent claudication has been studied in cardiovascular surveys but limited information is available on asymptomatic peripheral arterial disease. The purpose of this paper is to describe the prevalence of both asymptomatic and symptomatic disease and relation to ischaemic heart disease in the Edinburgh Artery Study. A cross-sectional survey was conducted on an age-stratified sample of men and women aged 55 to 74 years selected from age-sex registers in ten general practices in the city. Arterial disease was assessed in 1592 participants by means of the WHO questionnaire on intermittent claudication and measurement of the ankle brachial systolic pressure index (ABPI) and change in ankle systolic pressure during reactive hyperaemia. The prevalence of intermittent claudication was 4.5% (95% confidence interval (CI): 3.5%-5.5%). Major asymptomatic disease causing a significant impairment of blood flow occurred in 8.0% (95% CI: 6.6%-9.4%). A further 16.6% (95% CI: 14.6%-18.5%) had criteria considered abnormal in clinical practice: 9.0% had ABPI less than 0.9 and 7.6% had reactive hyperaemia pressure reduction greater than 20%. Intermittent claudication was equally common in both sexes. The ABPI and reactive hyperaemia results suggested a slight preponderance of asymptomatic disease in males and were consistent with an increasing prevalence with age and lower social class. Mean ABPI was higher in normal men than women, and was lower in the left leg than the right suggesting a unilateral predisposition to disease. Subjects with major asymptomatic disease had more evidence of ischaemic heart disease than in the normal population (relative risk (RR) 1.6; 95% CI: 1.3-1.9).(ABSTRACT TRUNCATED AT 250 WORDS)